Richard Gill Richard Gill runs the biosciences division of a global technology transfer company, calling himself "a mercenary technologist." It's an aggressive line of work--mining unsung discoveries at universities, drug companies, and eccentric inventors' garages; obtaining licensing agreements; and getting finished product out into the marketplace. "I use harsher language to describe what I do than 'merchant scientist,'" the popular moniker for his job, says Gill, the senior vice president
 Richard Gill |
A United Kingdom-based company, BTG holds more than 8,500 patents in 250 different technologies. Gill is one of a team of 40 scientists, patent attorneys, and finance and business people at BTG in the United States (the London office has 140), all of ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Felix Lansing will discuss how AI-driven models improve recombinase development.
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model
Zymo Research, a global leader in sample preparation technologies and sustainable life science solutions, will partner with Harvard University to host the BioFestival on October 18, 2025.
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
